Disinfecting composition and methods of making and using same

Details for Australian Patent Application No. 2004287281 (hide)

Owner Veckis Industries Ltd.

Inventors Ermilov, Valeriy Vasilievich; Kuzmin, Vladimir Semenovich; Polyakov, Viktor Stanislavovich; Lukashov, Oleg Ivanovich

Agent Pizzeys

Pub. Number AU-A-2004287281

PCT Pub. Number WO2005/044287

Priority 60/518,891 11.11.03 US; 60/523,190 13.11.03 US

Filing date 11 November 2004

Wipo publication date 19 May 2005

International Classifications

A61K 33/34 (2006.01) Medicinal preparations containing inorganic active ingredients - Copper

A61K 33/24 (2006.01) Medicinal preparations containing inorganic active ingredients - Heavy metals

A61K 33/30 (2006.01) Medicinal preparations containing inorganic active ingredients - Zinc

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/22 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Heterocyclic compounds

Event Publications

6 July 2006 PCT application entered the National Phase

  PCT publication WO2005/044287 Priority application(s): WO2005/044287

14 August 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004287283-Human anti IL-15 antibody 146B7 inducing monocytes apoptosis, therapeutical uses thereof

2004287277-Desensitization of complement activation using monocyte/macrophage inhibitory compounds